Vault-13

Foresite Capital Opportunity Management V, LLC

Larkspur, CA · CIK 1792207 · 13F filing filed 2022-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$33.3m reported value
9positions
100.0%in top 10
—no comparable previous quarter

Holdings, Q3 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PARDES BIOSCIENCES INC COM COM 5,227,307 $9.7m29.04% 29.04% —
2 THESEUS PHARMACEUTICALS INC COM COM 959,275 $5.6m16.71% 16.71% —
3 GEMINI THERAPEUTICS INC COM COM 2,435,125 $4.0m11.99% 11.99% —
4 COMPASS THERAPEUTICS INC COM CMPX CMPX 1,554,250 $3.5m10.64% 10.64% —
5 KINNATE BIOPHARMA INC COM KNTE KNTE 291,667 $3.5m10.46% 10.46% —
6 ADICET BIO INC COM COM 170,000 $2.4m7.26% 7.26% —
7 QUANTUM SI INC COM CL A QSI QSI 633,626 $1.7m5.23% 5.23% —
8 HIMS & HERS HEALTH INC COM CL A HIMS HIMS 306,431 $1.7m5.13% 5.13% —
9 ENANTA PHARMACEUTICALS INC COM ENTA ENTA 22,750 $1.2m3.54% 3.54% —